X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-12 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $385.42 | -8,358 | 29,678 | -22% | -$3,221,340 | |||||
2024-05-09 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale | $316.88 | -6,311 | 29,624 | -18% | -$1,999,825 | ||||||
| D | 2024-05-06 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $309.00 | -1,600 | 35,935 | -4% | -$494,400 | |||||
| D | 2024-01-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $306.79 | -3,200 | 24,929 | -11% | -$981,734 | |||||
2023-04-28 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale | $284.44 | -12,556 | 28,783 | -30% | -$3,571,396 | ||||||
| D | 2023-02-01 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $257.11 | -4,000 | 20,823 | -16% | -$1,028,440 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |